Literature DB >> 8067738

Antibiotic penetration of and bactericidal activity within endothelial cells.

R O Darouiche1, R J Hamill.   

Abstract

It has been observed that the number of cases of infective endocarditis arising in patients who have no previous identifiable cardiac abnormalities is increasing, suggesting that direct bacterial interactions with endothelium may occur. Furthermore, the prolonged natural history of endocarditis, need for lengthy therapy, and frequency of relapse suggest that intracellular bacteria that may be protected from antimicrobial action and host responses exist. Using high-performance liquid chromatography, we investigated the penetration of seven antibiotics used to treat Staphylococcus aureus infections into cultured human umbilical vein endothelial cells and the effect of these antibiotics on the intracellular killing of two strains of the organism. In general, endothelial cell penetration of lipophilic drugs, such as minocycline, ciprofloxacin, and rifampin, exceeded that of hydrophilic drugs, represented by nafcillin, cefazolin, cefuroxime, and vancomycin. Bacterial killing paralleled the intracellular penetration of all the antibiotics except rifampin, which concentrated well inside cells but had poor killing activity. However, when combined with the other antibiotics, rifampin potentiated their killing activity against intracellular S. aureus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8067738      PMCID: PMC188150          DOI: 10.1128/AAC.38.5.1059

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  43 in total

Review 1.  Concepts on the use of liposomal antimicrobial agents: applications for aminoglycosides.

Authors:  J A Karlowsky; G G Zhanel
Journal:  Clin Infect Dis       Date:  1992-10       Impact factor: 9.079

2.  ENDOTHELIAL PHAGOCYTOSIS: AN ELECTRON-MICROSPOPIC STUDY.

Authors:  R S COTRAN
Journal:  Exp Mol Pathol       Date:  1965-04       Impact factor: 3.362

3.  The action of isoniazid (isonicotinic acid hydrazide) on intracellular tubercle bacilli.

Authors:  G B MACKANESS; N SMITH
Journal:  Am Rev Tuberc       Date:  1952-08

4.  Early Lesions of Experimental Endocarditis Lenta.

Authors:  W J Macneal; M J Spence; A E Slavkin
Journal:  Am J Pathol       Date:  1943-09       Impact factor: 4.307

5.  A human endothelial cell membrane protein that binds Staphylococcus aureus in vitro.

Authors:  D C Tompkins; V B Hatcher; D Patel; G A Orr; L L Higgins; F D Lowy
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

Review 6.  The importance of penetration of antimicrobial agents into cells.

Authors:  J C Schwab; G L Mandell
Journal:  Infect Dis Clin North Am       Date:  1989-09       Impact factor: 5.982

7.  Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin.

Authors:  W M Scheld; J A Valone; M A Sande
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

8.  Eradication of colonization by methicillin-resistant Staphylococcus aureus by using oral minocycline-rifampin and topical mupirocin.

Authors:  R Darouiche; C Wright; R Hamill; M Koza; D Lewis; J Markowski
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

9.  Identification of Staphylococcus aureus binding proteins on isolated porcine cardiac valve cells.

Authors:  K M Campbell; C M Johnson
Journal:  J Lab Clin Med       Date:  1990-02

10.  Specific binding of Staphylococcus aureus to cultured porcine cardiac valvular endothelial cells.

Authors:  C M Johnson; G A Hancock; G D Goulin
Journal:  J Lab Clin Med       Date:  1988-07
View more
  24 in total

1.  In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations.

Authors:  Samuel A Shelburne; Daniel M Musher; Kristina Hulten; Heather Ceasar; Michael Y Lu; Imran Bhaila; Richard J Hamill
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

2.  Differential intracellular efficacies of ciprofloxacin and cefixime against Neisseria gonorrhoeae in human fallopian tube organ culture.

Authors:  J P Phanucharas; G L Gorby
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

Review 3.  Recalcitrant Staphylococcus aureus Infections: Obstacles and Solutions.

Authors:  Sarah E Rowe; Jenna E Beam; Brian P Conlon
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

4.  Cationic antimicrobial peptide LL-37 is effective against both extra- and intracellular Staphylococcus aureus.

Authors:  Jabeen Noore; Adly Noore; Bingyun Li
Journal:  Antimicrob Agents Chemother       Date:  2012-12-28       Impact factor: 5.191

5.  Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.

Authors:  George Sakoulas; George M Eliopoulos; Jeff Alder; Claudie Thauvin Eliopoulos
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

Review 6.  Predictors of mortality in Staphylococcus aureus Bacteremia.

Authors:  Sebastian J van Hal; Slade O Jensen; Vikram L Vaska; Björn A Espedido; David L Paterson; Iain B Gosbell
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

7.  Chronic prosthetic hip infection caused by a small-colony variant of Escherichia coli.

Authors:  A Roggenkamp; A Sing; M Hornef; U Brunner; I B Autenrieth; J Heesemann
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

8.  Uptake of cefepime by phagocytosing polymorphonuclear neutrophils and subsequent intracellular killing.

Authors:  H Pruul; P J McDonald
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

9.  Intracellular activity of vancomycin and Ly333328, a new semisynthetic glycopeptide, against methicillin-resistant Staphylococcus aureus.

Authors:  B al-Nawas; P M Shah
Journal:  Infection       Date:  1998 May-Jun       Impact factor: 3.553

Review 10.  Rifampin combination therapy for nonmycobacterial infections.

Authors:  Graeme N Forrest; Kimberly Tamura
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.